Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Hormones
Published in: Hormones 2/2016

01-04-2016 | Research paper

Vitamin D levels in a large Mediterranean cohort: reconsidering normal cut-off values

Authors: Marianna Katrinaki, Marilena Kampa, Andrew Margioris, Elias Castanas, Niki Malliaraki, MD, PhD

Published in: Hormones | Issue 2/2016

Login to get access
Metadata
Title
Vitamin D levels in a large Mediterranean cohort: reconsidering normal cut-off values
Authors
Marianna Katrinaki
Marilena Kampa
Andrew Margioris
Elias Castanas
Niki Malliaraki, MD, PhD
Publication date
01-04-2016
Publisher
Springer International Publishing
Published in
Hormones / Issue 2/2016
Print ISSN: 1109-3099
Electronic ISSN: 2520-8721
DOI
https://doi.org/10.14310/horm.2002.1674

Other articles of this Issue 2/2016

Hormones 2/2016 Go to the issue

Research paper

Clinical impact of strict criteria for selectivity and lateralization in adrenal vein sampling

Review

Effects of ghrelin in energy balance and body weight homeostasis

Research paper

The gonadotroph origin of null cell adenomas

Research paper

Comparison of color-Doppler and qualitative and quantitative strain-elastography for differentiation of thyroid nodules in daily practice

Case report

Adrenal malignant melanoma masquerading as a pheochromocytoma in a patient with a history of a multifocal papillary and medullary thyroid carcinoma

Research paper

Genetic screening of non-classic CAH females with hyperandrogenemia identifies a novel CYP11B1 gene mutation
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits